Logo image of HSON

HUDSON GLOBAL INC (HSON) Stock Fundamental Analysis

NASDAQ:HSON - Nasdaq - US4437872058 - Common Stock - Currency: USD

8.85  -0.15 (-1.67%)

Fundamental Rating

4

Taking everything into account, HSON scores 4 out of 10 in our fundamental rating. HSON was compared to 82 industry peers in the Professional Services industry. HSON has a great financial health rating, but its profitability evaluates not so good. HSON has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

HSON had negative earnings in the past year.
HSON had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: HSON reported negative net income in multiple years.
In multiple years HSON reported negative operating cash flow during the last 5 years.
HSON Yearly Net Income VS EBIT VS OCF VS FCFHSON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M -20M

1.2 Ratios

HSON's Return On Assets of -6.82% is on the low side compared to the rest of the industry. HSON is outperformed by 75.61% of its industry peers.
HSON has a Return On Equity of -9.19%. This is in the lower half of the industry: HSON underperforms 71.95% of its industry peers.
Industry RankSector Rank
ROA -6.82%
ROE -9.19%
ROIC N/A
ROA(3y)1.66%
ROA(5y)1.52%
ROE(3y)2.74%
ROE(5y)2.57%
ROIC(3y)N/A
ROIC(5y)N/A
HSON Yearly ROA, ROE, ROICHSON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

Looking at the Gross Margin, with a value of 50.87%, HSON is in the better half of the industry, outperforming 63.41% of the companies in the same industry.
HSON's Gross Margin has improved in the last couple of years.
HSON does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.51%
GM growth 5Y1.51%
HSON Yearly Profit, Operating, Gross MarginsHSON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

HSON does not have a ROIC to compare to the WACC, probably because it is not profitable.
HSON has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, HSON has less shares outstanding
HSON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
HSON Yearly Shares OutstandingHSON Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
HSON Yearly Total Debt VS Total AssetsHSON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

HSON has an Altman-Z score of -7.20. This is a bad value and indicates that HSON is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -7.20, HSON is not doing good in the industry: 92.68% of the companies in the same industry are doing better.
HSON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -7.2
ROIC/WACCN/A
WACC9.1%
HSON Yearly LT Debt VS Equity VS FCFHSON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

A Current Ratio of 3.22 indicates that HSON has no problem at all paying its short term obligations.
The Current ratio of HSON (3.22) is better than 86.59% of its industry peers.
HSON has a Quick Ratio of 3.22. This indicates that HSON is financially healthy and has no problem in meeting its short term obligations.
HSON has a better Quick ratio (3.22) than 87.80% of its industry peers.
Industry RankSector Rank
Current Ratio 3.22
Quick Ratio 3.22
HSON Yearly Current Assets VS Current LiabilitesHSON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for HSON have decreased strongly by -229.73% in the last year.
Looking at the last year, HSON shows a decrease in Revenue. The Revenue has decreased by -9.29% in the last year.
HSON shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.35% yearly.
EPS 1Y (TTM)-229.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.89%
Revenue 1Y (TTM)-9.29%
Revenue growth 3Y-6.11%
Revenue growth 5Y8.35%
Sales Q2Q%-5.98%

3.2 Future

Based on estimates for the next years, HSON will show a very strong growth in Earnings Per Share. The EPS will grow by 84.94% on average per year.
HSON is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.06% yearly.
EPS Next Y91.61%
EPS Next 2Y84.94%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.63%
Revenue Next 2Y2.06%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HSON Yearly Revenue VS EstimatesHSON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
HSON Yearly EPS VS EstimatesHSON Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

HSON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 3.94, the valuation of HSON can be described as very cheap.
97.56% of the companies in the same industry are more expensive than HSON, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.17. HSON is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 3.94
HSON Price Earnings VS Forward Price EarningsHSON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HSON Per share dataHSON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

HSON's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as HSON's earnings are expected to grow with 84.94% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y84.94%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HSON!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HUDSON GLOBAL INC

NASDAQ:HSON (6/3/2025, 4:30:02 PM)

8.85

-0.15 (-1.67%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)05-13 2025-05-13/bmo
Earnings (Next)08-06 2025-08-06
Inst Owners67.52%
Inst Owner Change-1.59%
Ins Owners18.49%
Ins Owner Change0.23%
Market Cap24.34M
Analysts82.86
Price Target19.38 (118.98%)
Short Float %0.22%
Short Ratio1.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-142.03%
Min EPS beat(2)-261.52%
Max EPS beat(2)-22.55%
EPS beat(4)0
Avg EPS beat(4)-161.66%
Min EPS beat(4)-261.52%
Max EPS beat(4)-22.55%
EPS beat(8)1
Avg EPS beat(8)-334.82%
EPS beat(12)2
Avg EPS beat(12)-239.79%
EPS beat(16)5
Avg EPS beat(16)-171.92%
Revenue beat(2)0
Avg Revenue beat(2)-7.4%
Min Revenue beat(2)-11.38%
Max Revenue beat(2)-3.43%
Revenue beat(4)0
Avg Revenue beat(4)-8.8%
Min Revenue beat(4)-20.37%
Max Revenue beat(4)-0.04%
Revenue beat(8)0
Avg Revenue beat(8)-8.74%
Revenue beat(12)1
Avg Revenue beat(12)-7.83%
Revenue beat(16)5
Avg Revenue beat(16)-3.81%
PT rev (1m)0%
PT rev (3m)-13.64%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-157.14%
EPS NY rev (1m)0%
EPS NY rev (3m)-120.63%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-10.42%
Revenue NY rev (1m)-0.35%
Revenue NY rev (3m)-11.45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3.94
P/S 0.18
P/FCF N/A
P/OCF N/A
P/B 0.62
P/tB 0.77
EV/EBITDA N/A
EPS(TTM)-1.22
EYN/A
EPS(NY)2.24
Fwd EY25.36%
FCF(TTM)-0.66
FCFYN/A
OCF(TTM)-0.66
OCFYN/A
SpS50.19
BVpS14.35
TBVpS11.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.82%
ROE -9.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.87%
FCFM N/A
ROA(3y)1.66%
ROA(5y)1.52%
ROE(3y)2.74%
ROE(5y)2.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.51%
GM growth 5Y1.51%
F-Score6
Asset Turnover2.6
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.2%
Cap/Sales 0.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.22
Quick Ratio 3.22
Altman-Z -7.2
F-Score6
WACC9.1%
ROIC/WACCN/A
Cap/Depr(3y)14.77%
Cap/Depr(5y)20.42%
Cap/Sales(3y)0.11%
Cap/Sales(5y)0.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-229.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.89%
EPS Next Y91.61%
EPS Next 2Y84.94%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.29%
Revenue growth 3Y-6.11%
Revenue growth 5Y8.35%
Sales Q2Q%-5.98%
Revenue Next Year-3.63%
Revenue Next 2Y2.06%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-55.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year157.35%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-128.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-126.18%
OCF growth 3YN/A
OCF growth 5YN/A